0001493152-24-010575.txt : 20240319
0001493152-24-010575.hdr.sgml : 20240319
20240319215258
ACCESSION NUMBER: 0001493152-24-010575
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Latkin Jed
CENTRAL INDEX KEY: 0001554593
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 24766200
MAIL ADDRESS:
STREET 1: 152 W. 57TH STREET
STREET 2: 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
BUSINESS PHONE: (215) 345-0919
MAIL ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0508
4
2024-01-01
0
0000868278
ProPhase Labs, Inc.
PRPH
0001554593
Latkin Jed
711 STEWART AVE., SUITE 200
GARDEN CITY,
NY
11530
1
0
0
0
0
Option (right to buy)
6.00
2024-01-01
4
A
0
500000
0.00
A
2031-01-01
Common Stock
500000
500000
D
The option vests over a three year period, with 25% vesting on the date of grant and 25% vesting on each anniversary thereafter, subject to the Reporting Person's continued service through each vesting date
/s/ Jed Latkin
2024-03-19